Háskóli Íslands

DENOVO-RBC

DENOVO-RBC

Verkefnanúmer: 641093
Styrkur í samræmi við: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Developing Novel and Optimal Additive Solutions for Red Blood Cells

Upphafsdagur

Lokadagur

Staða

1. mars 2015

31. ágúst 2016

Lokið

Um verkefnið:

Heildarkostnaður
EUR 150.000

Viðfangsefni:
ERC-PoC-2014 - ERC Proof of Concept Grant

Heildarstyrkur
EUR 150.000

Styrkur sóttur í:
ERC-2014-PoC

Stýrt af:
Háskóli Íslands

Tegund styrks:
ERC-POC - Proof of Concept Grant
 

Nánari upplýsingar um verkefnið má finna hér.

Markmið

The research conducted in SYSTEM_US (ERC Advanced Grant #232816) has led to the discovery of valuable biomarkers for the quality of red blood cells (RBCs) in standard blood bank storage conditions. Using a combination of systems biology and metabolomics, this discovery will lead to the development of novel RBC storage technologies including additive solutions and diagnostics. These technologies will become valuable assets in the form of intellectual property to large transfusion medicine companies and will save thousands of lives over the coming decades. This proposal covers the needs to fully define the market and NPV of the developing technology, fully define the regulatory and clinical path of product approval, file for patents to protect the intellectual property, conduct necessary validation experiments, and continue to develop relations with industry contacts.

Verkefnastýring (e. Coordinator)

Háskóli Íslands (UoI)                                                  Iceland

Þátttakendur

Stykrþegar:

Háskóli Íslands

Iceland

 

Þú ert að nota: brimir.rhi.hi.is